Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in...
Healthcare
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-CalMALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE)...
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
DALLAS, TEXAS, July 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on...
Fortrea Appoints Robert Parks as Chief Accounting Officer
DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced...
3Daughters Secures $4.7 Million in Oversubscribed Seed Round
Funds will support development of game-changing IUD (intrauterine device) for contraception through an IND filing in early 2025MANSFIELD, Mass., July...
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic...
Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024
ORANGE, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2024 financial...
Samsung Bioepis Releases Third Quarter 2024 US Biosimilar Market Report
Addresses frequently asked questions on biosimilar interchangeability and its exclusivity Includes an interview with Scripius’ pharmacy benefit manager on their...
Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium
Hematology Oncology of Indiana’s M. Sarfraz Nawaz, MD, investigated improvement in approaches to febrile neutropenia in cancer patients Indianapolis Medical...
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11, 2024 (GLOBE...
Derek Chaves Appointed Chief Financial Officer of Corza Medical
WESTWOOD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”) is proud to announce the appointment...
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in...
Hydreight Expands Its “At-Home Blood Testing” Solution with More Tests to All 50 States
In a joint-venture with a national laboratory, Hydreight and its medical network are expanding at-home lab tests spanning a range...
Indegene Announces Strategic Collaboration with Microsoft to Help Life Sciences Companies Scale Up Generative AI Adoption and Accelerate Business Impact
PRINCETON, N.J. and BENGALURU, India, July 11, 2024 (GLOBE NEWSWIRE) -- Indegene today announced a strategic collaboration with Microsoft to...
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential
Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001...
ICPO Foundation partners with the American Hospital Dubai to establish an ICPO Collaborating Center in the Middle East.
This cooperation strengthens global educational standards for radiotheranostics and will scale patient access to a new generation of effective cancer...
Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec
Bagsværd, Denmark, 10 July 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued...
MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation
NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces...
Official Swiss delegation experiences new frontiers in art tech at HKBU
HONG KONG, July 11, 2024 /PRNewswire/ -- A senior Swiss delegation led by Mr Guy Parmelin, Swiss Federal Councillor and Head...